Clinical Trial Update: Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating weekly paclitaxel and cisplatin followed by radical hysterectomy in patients with FIGO IB2 to IIA2 cervical cancer; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN